US FY2027 Major Drug Transit and Illicit Drug Producing Countries List: India, China, and Pakistan Included
The United States has released its Fiscal Year 2027 (FY2027) Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries, naming 23 countries including India, China, and Pakistan. This list identifies nations involved in significant drug transit or illicit production based on geographic, commercial, and economic factors facilitating drug movements. While inclusion does not necessarily indicate failure in anti-narcotics efforts, the US highlights China’s role in precursor chemical production, India's strides in opium control, and Pakistan’s designated transit status. Countries such as Afghanistan, Bolivia, Burma, and Colombia were separately identified as having failed demonstrably in counternarcotics efforts. This annual designation shapes US counternarcotics policy and international cooperation priorities.
On this page

Key Facts
- The US FY2027 list identifies 23 countries as major drug transit or illicit drug producing nations.
- India, China, and Pakistan are included, maintaining their presence from the previous FY2026 list.
- China is noted as a major producer of precursor chemicals used to manufacture fentanyl, methamphetamine, and other synthetic drugs.
- India is recognized for efforts to combat illicit opium poppy cultivation and to strengthen supply-chain integrity, with ongoing cooperation under the US-India Drug Policy Framework.
- Pakistan is included in the FY2027 list but is not designated among countries that have “failed demonstrably” to meet international counternarcotics obligations in the last 12 months.
- Afghanistan, Bolivia, Burma (Myanmar), and Colombia are separately designated as having failed demonstrably in meeting international counternarcotics obligations for FY2027.
- This annual designation influences US foreign assistance, law enforcement cooperation, and counternarcotics policy formulations.
Background & Context
The Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries is an annual executive document submitted to the US Congress, mandated by the Foreign Relations Authorization Act (FRAA). The list identifies countries linked to illicit drug transit or production based on a combination of geographic, commercial, and economic factors that facilitate the movement of drugs or precursor chemicals, regardless of a government’s actual efforts. This ensures that countries are not automatically labeled as negligent if they engage in robust anti-narcotics measures. The list serves as a strategic tool guiding US foreign policy, including bilateral cooperation, aid allocation, and pressing countries to improve their counternarcotics efforts.
Why This Matters for Exams
The US majors list is often a significant topic in international relations and current affairs sections of competitive exams, especially those focusing on US-India diplomacy, global drug control strategies, and international law enforcement cooperation. Understanding the nuances of which countries are included, the criteria for inclusion, and the diplomatic implications—such as India’s recognized efforts or China’s role in precursor chemicals—is valuable. Moreover, knowledge about countries designated as having failed obligations (Afghanistan, Bolivia, Burma, Colombia) aids in grasping US foreign aid and sanctions policies.
Points to Remember
- FY2027 list includes 23 countries: Afghanistan, The Bahamas, Belize, Bolivia, Burma (Myanmar), China, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, India, Jamaica, Laos, Mexico, Nicaragua, Pakistan, Panama, Peru, Venezuela.
- China is the world’s largest producer of many precursor chemicals used in illicit synthetic drugs and is urged by the US to expand chemical scheduling and enforcement.
- India is commended for tackling illicit opium poppy cultivation and maintaining cooperation under the US-India Drug Policy Framework.
- Pakistan is included but not among those that failed demonstrably in counternarcotics obligations.
- Four countries are designated as having failed demonstrably in past 12 months: Afghanistan, Bolivia, Burma, and Colombia.
- Inclusion on the list is based on multiple factors, not solely on a country’s enforcement or policy actions.
Practice MCQs
Question 1
- India, China, and Pakistan are labeled as failing demonstrably in the US FY2027 drug transit list.
- China is the major producer of precursor chemicals used in synthetic drugs.
- Pakistan is excluded from the FY2027 drug transit list.
- Afghanistan is not on the FY2027 list.
Answer: 2
Question 2
- The US FY2027 list contains 15 countries.
- India’s efforts in fighting illicit opium poppy cultivation were appreciated by the US.
- Only China is recognized for precursor chemical production among Asian countries.
- Pakistan is designated as having failed demonstrably on counternarcotics obligations.
Answer: 2
Question 3
- Afghanistan, Bolivia, Burma, and Colombia were designated for failing counternarcotics efforts in FY2027.
- India replaced Pakistan on the FY2027 list.
- China rejected US requests regarding chemical precursors before FY2027.
- Pakistan is the only South Asian country removed from the FY2027 list.
Answer: 1
Sources & Further Reading
| Document / Website | Link |
|---|---|
| US Names India, China and Pakistan in Drug Transit List – GKToday | Open US Names India, China and Pakistan in Drug Transit List – GKToday ↗www.gktoday.in |
| Presidential Determination on Major Drug Transit or Major ... | Open Presidential Determination on Major Drug Transit or Major ... ↗www.state.gov |
| President Trump Designates the 2027 “Major’s List” – The White House | Open President Trump Designates the 2027 “Major’s List” – The White House ↗www.whitehouse.gov |
| 2026 National Drug Control Strategy Released – The White House | Open 2026 National Drug Control Strategy Released – The White House ↗whitehouse.gov |